BTAI
BioXcel Therapeutics Inc.
Company Overview
| Mkt Cap | $43.52M | Price | $2.05 |
| Volume | 556.67K | Change | +1.49% |
| P/E Ratio | -0.7 | Open | $2.04 |
| Revenue | $2.3M | Prev Close | $2.02 |
| Net Income | $-59.6M | 52W Range | $1.17 - $12.16 |
| Div Yield | N/A | Target | $8.25 |
| Overall | 32 | Value | 40 |
| Quality | 39 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyBioXcel Therapeutics Inc. (BTAI) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.05 with a market capitalization of $43.52 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows BTAI with a volume of 557K shares. The stock opened up 0.99% from yesterday's close of $2.02. Current analyst estimates project earnings of $-6.93 per share for this year, with next year targeting $-4.8.
BTAI demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BTAI include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 302.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:36 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BTAI | $2.05 | +1.5% | 556.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioXcel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW